Full-Time

Medical Director Oncology

Confirmed live in the last 24 hours

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops monoclonal antibodies for infectious diseases

AI & Machine Learning
Biotechnology

Compensation Overview

$194k - $284kAnnually

Senior

No H1B Sponsorship

San Francisco, CA, USA

Requires onsite presence in San Francisco for four days per week.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • M.D. degree with 5+ years of relevant industry experience and the completion of a subspecialty fellowship in oncology is highly desirable.
  • Experience in Oncology is required.
  • Demonstrated ability to independently evaluate, interpret and present complex scientific data.
  • Ability to run a clinical research program of complexity with moderate supervision.
  • Experienced with engaging internal and external experts in constructive scientific and clinical dialog around study design, study conduct, and interpretation of clinical results.
  • Demonstrated ability to work within a multi-disciplinary team of peers and outside experts.
  • Solid interpersonal skills, as well as the ability to function in a team environment.
  • Ability to adapt and learn quickly in new areas of research, clinical development, and have resourcefulness to independently gather relevant information.
Responsibilities
  • Contribute to clinical development planning and clinical strategy.
  • Provides clinical leadership and medical strategic input for all clinical deliverables of your programs.
  • Clinical deliverables may include clinical sections of individual protocols, clinical data review, program specific standards, clinical components of regulatory documents/registration dossiers, and publications.
  • Represent clinical research in relevant sub-teams.
  • Review all key documentation such as IND/CTA, health authority communications and other documents (DUSR, INDAR, DRMP, RMP, etc), protocols and amendments.
  • Work collaboratively with regulatory and other functions to deliver the clinical research components in the preparation/review of regulatory documents, IND annual reports, IND safety reports, and investigator brochures.
  • Provide ongoing medical and data monitoring for clinical trials including, but not limited to, assessment of eligibility criteria, toxicity management and drug safety surveillance.
  • Keeps abreast of the highest standards and levels of scientific and clinical knowledge in relevant therapeutic and disease area(s).
  • Review all data generated across the program to update strategy and risk assessment.
  • Collaborates with external partners, regulators, and diverse internal stakeholders and collaborators.
  • Serve as a scientific and clinical resource within Vir. Providing scientific and clinical guidance to other relevant functions (eg, research, toxicology, clinical pharmacology, development operations, regulatory, project management, etc).

Vir Biotechnology develops treatments for infectious diseases by harnessing the immune system, using a proprietary platform for monoclonal antibodies (mAbs) combined with machine learning and artificial intelligence. Their pipeline includes clinical candidates for hepatitis B, hepatitis delta, and HIV, as well as monoclonal antibodies targeting influenza, COVID-19, and human papillomavirus. What distinguishes Vir from competitors is its collaboration with industry leaders and organizations to expedite scientific advancements. The company's goal is to transform lives by addressing unmet medical needs.

Company Stage

Grant

Total Funding

$640.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

2%

1 year growth

5%

2 year growth

8%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement